100 related articles for article (PubMed ID: 26024595)
1. Histone deacetylase HDAC1 downregulates transcription of the serotonin transporter (5-HTT) gene in tumor cells.
Phi van DK; Mühlbauer E; Phi-van L
Biochim Biophys Acta; 2015 Aug; 1849(8):909-18. PubMed ID: 26024595
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serotonin transporter expression by C/EBPβ in LPS-activated macrophage cells (HD11).
Zimmermann K; van Phi VD; Brase A; Phi-van L
Innate Immun; 2015 May; 21(4):406-15. PubMed ID: 25213348
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
4. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
Zhao S; Venkatasubbarao K; Li S; Freeman JW
Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
Lee SH; Kim J; Kim WH; Lee YM
Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
[TBL] [Abstract][Full Text] [Related]
6. Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2.
Gill RK; Kumar A; Malhotra P; Maher D; Singh V; Dudeja PK; Alrefai W; Saksena S
Am J Physiol Cell Physiol; 2013 Feb; 304(4):C334-41. PubMed ID: 23195070
[TBL] [Abstract][Full Text] [Related]
7. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter.
Lee KJ; Lee KY; Lee YM
Biochim Biophys Acta; 2010 May; 1803(5):608-16. PubMed ID: 20080132
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN; Kim NH; Lee W; Seo DW; Kim YK
Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
[TBL] [Abstract][Full Text] [Related]
10. Dynamic histone acetylation/deacetylation with progesterone receptor-mediated transcription.
Aoyagi S; Archer TK
Mol Endocrinol; 2007 Apr; 21(4):843-56. PubMed ID: 17227884
[TBL] [Abstract][Full Text] [Related]
11. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
[TBL] [Abstract][Full Text] [Related]
12. Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells.
Gray SG; Ekström TJ
Biochem Biophys Res Commun; 1998 Apr; 245(2):423-7. PubMed ID: 9571167
[TBL] [Abstract][Full Text] [Related]
13. Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.
Lu H; Pise-Masison CA; Linton R; Park HU; Schiltz RL; Sartorelli V; Brady JN
J Virol; 2004 Jul; 78(13):6735-43. PubMed ID: 15194748
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of histone deacetylase 1 (HDAC1) but not HDAC2 is required for the glucocorticoid-dependent CCAAT/enhancer-binding protein α (C/EBPα) expression and preadipocyte differentiation.
Kuzmochka C; Abdou HS; Haché RJ; Atlas E
Endocrinology; 2014 Dec; 155(12):4762-73. PubMed ID: 25203139
[TBL] [Abstract][Full Text] [Related]
15. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of Aurora-A gene by wild-type p53 through directly binding to its promoter with histone deacetylase 1 and mSin3a.
Yang TY; Teng CJ; Lin TC; Chen KC; Hsu SL; Wu CC
Int J Cancer; 2018 Jan; 142(1):92-108. PubMed ID: 28884479
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
Law AY; Lai KP; Lui WC; Wan HT; Wong CK
Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
[TBL] [Abstract][Full Text] [Related]
18. Role for histone deacetylase 1 in human tumor cell proliferation.
Senese S; Zaragoza K; Minardi S; Muradore I; Ronzoni S; Passafaro A; Bernard L; Draetta GF; Alcalay M; Seiser C; Chiocca S
Mol Cell Biol; 2007 Jul; 27(13):4784-95. PubMed ID: 17470557
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin F2alpha suppresses rat steroidogenic acute regulatory protein expression via induction of Yin Yang 1 protein and recruitment of histone deacetylase 1 protein.
Liu Q; Merkler KA; Zhang X; McLean MP
Endocrinology; 2007 Nov; 148(11):5209-19. PubMed ID: 17702849
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
